About Index Trending news
Lists
Pricing

Therapeutics

200+ Companies
More info
Parent markets
Sibling markets
Related markets
200+ companies in Therapeutics
Show all
Amgen Inc.

Amgen Inc.

Manufacturing +2
Seattle Genetics

Seattle Genetics

Health Care +2
Takeda

Takeda

Pharmaceuticals +1
Appili Therapeutics

Appili Therapeutics

Biotechnology +2
Puma Biotechnology

Puma Biotechnology

Biotechnology +1
Enterprise Therapeutics

Enterprise Therapeutics

Health and Wellness +4
Neuronetics, Inc.

Neuronetics, Inc.

Biotechnology +2
Arthro Therapeutics

Arthro Therapeutics

Cloud Computing +6
Cyteir

Cyteir

Biotechnology +1
Neos Therapeutics, Inc.

Neos Therapeutics, Inc.

Biotechnology +2
Nuritas

Nuritas

Data Mining +3
Scholar Rock

Scholar Rock

Medical +2
Cidara Therapeutics

Cidara Therapeutics

Health Care +2
RubrYc Therapeutics

RubrYc Therapeutics

Health Care +1
Aspyrian Therapeutics

Aspyrian Therapeutics

Biotechnology +1
All companies in Therapeutics
Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2018
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

18 Apr 2018
Grid Therapeutics
Grid Therapeutics
$4,500,000
Venture capital (Series B)
Milestone Holdings, Paul Funk, Jeffery "TJ" Heyman

Grid Therapeutics Closes Series B Financing

Venture Funding News
13 Apr 2018
Sollis Therapeutics
Sollis Therapeutics
$50,000,000
Venture capital (Series A)
Deerfield Management

Sollis Therapeutics Receives up to $50m Investment from Deerfield Management

FinSMEs
12 Apr 2018
Enterprise Therapeutics
Enterprise Therapeutics
£29,000,000
Venture capital (Series B)
Novartis Venture Fund, Epidarex Capital, Versant Ventures, +2

Enterprise Therapeutics raises 29 mln pounds

PE Hub
11 Apr 2018
RubrYc Therapeutics
RubrYc Therapeutics
$10,000,000
Venture capital (Series A)
Third Point Ventures, Paladin Capital Group, Vital Venture Capital, +1

RubrYc Therapeutics Inks $10M Series A Round

Venture Funding News
+2
10 Apr 2018
Promethera Biosciences
Promethera Biosciences
€9,300,000
Debt financing
Shinsei Corporate Investment Limited, Shibuya Corporation

Promethera Biosciences Raises Additional €9.3M in Funding

FinSMEs
10 Apr 2018
Zucara Therapeutics
Zucara Therapeutics
$3,900,000
Venture capital
The Leona M. and Harry B. Helmsley Charitable Trust

Zucara Therapeutics Secures US$3.9M in Non-Dilutive Funding

FinSMEs
09 Apr 2018
Sigilon Therapeutics
Sigilon Therapeutics
Undisclosed funding
Eli Lilly and Company

Sigilon Therapeutics Receives Investment from Eli Lilly and Company

FinSMEs
05 Apr 2018
Eidos Therapeutics
Eidos Therapeutics
$64,000,000
Venture capital (Series B)
RA Capital Management, Aisling Capital, Perceptive Advisors, +5

Eidos Therapeutics Closes $64M Series B Financing

FinSMEs
04 Apr 2018
Poseida Therapeutics
Poseida Therapeutics
$30,500,000
Venture capital (Series B)
Longitude Capital, Vivo Capital, Tavistock Group, +1

Poseida Therapeutics snags $30.5 mln Series B

PE Hub
+2
04 Apr 2018
Arvinas
Arvinas
$55,000,000
Venture capital (Series C)
Canaan Partners, RA Capital Management, New Leaf Venture Partners, +6

Arvinas Completes $55M Series C

Venture Funding News
+1
03 Apr 2018
Allogene Therapeutics
Allogene Therapeutics
Undisclosed funding
Vida Ventures

Allogene Therapeutics grabs funding from Vida Ventures

PE Hub
+1
29 Mar 2018
Tempest Therapeutics
Tempest Therapeutics
$70,000,000
Venture capital (Series B)
Foresite Capital, Fidelity Growth Partners Europe, Versant Ventures, +3

Tempest Therapeutics hauls in $70 mln Series B

PE Hub